Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis
| Autor: | Chunming Ding, Kypros H. Nicolaides, Grace Tin-Yun Chung, Rossa W.K. Chiu, Ageliki Gerovassili, Y.M. Dennis Lo, K.C. Allen Chan, Tse N. Leung, Sze W. Yeung, Stephen S.C. Chim, Tze K. Lau |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Genetic Markers
endocrine system Genotype Placenta Pregnancy Trimester Third Clinical Biochemistry Prenatal diagnosis Biology Polymerase Chain Reaction Andrology Fetus Pregnancy Prenatal Diagnosis Blood plasma medicine Humans False Negative Reactions Genotyping Rh-Hr Blood-Group System Tumor Suppressor Proteins Biochemistry (medical) Reproducibility of Results DNA DNA Methylation Molecular biology Actins Pregnancy Trimester First medicine.anatomical_structure Cell-free fetal DNA DNA methylation Chorionic villi Female |
| Zdroj: | Clinical Chemistry. 52:2211-2218 |
| ISSN: | 1530-8561 0009-9147 |
| DOI: | 10.1373/clinchem.2006.074997 |
| Popis: | Background: We recently demonstrated that the promoter of the RASSF1A gene is hypermethylated in the placenta and hypomethylated in maternal blood cells. This methylation pattern allows the use of methylation-sensitive restriction enzyme digestion for detecting the placental-derived hypermethylated RASSF1A sequences in maternal plasma. Methods: We performed real-time PCR after methylation-sensitive restriction enzyme digestion to detect placental-derived RASSF1A sequences in the plasma of 28 1st-trimester and 43 3rd-trimester pregnant women. We used maternal plasma to perform prenatal fetal rhesus D (RhD) blood group typing for 54 early-gestation RhD-negative women, with hypermethylated RASSF1A as the positive control for fetal DNA detection. Results: Hypermethylated RASSF1A sequences were detectable in the plasma of all 71 pregnant women. The genotype of plasma RASSF1A after enzyme digestion was identical to the fetal genotype in each case, thus confirming its fetal origin. Nineteen of the 54 pregnant women undergoing prenatal fetal RhD genotyping showed undetectable RHD sequences in their plasma DNA samples. The fetal DNA control, RASSF1A, was not detectable in 4 of the 19 women. Subsequent chorionic villus sample analysis revealed that 2 of these 4 women with negative RHD and RASSF1A signals were in fact carrying RhD-positive fetuses. Conclusions: Hypermethylated RASSF1A is a universal marker for fetal DNA and is readily detectable in maternal plasma. When applied to prenatal RhD genotyping, this marker allows the detection of false-negative results caused by low fetal DNA concentrations in maternal plasma. This new marker can also be applied to many other prenatal diagnostic and monitoring scenarios. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|